Treatment outcomes, comorbid disorders and PTSD

治疗结果、合并症和创伤后应激障碍

基本信息

项目摘要

DESCRIPTION (provided by applicant): The proposed study will examine the combined effects of trauma exposure and posttraumatic stress disorder (PTSD) on primary treatment outcomes among individuals with comorbid substance use disorders (SUDs) and severe mental illness (SMI) with attention to gender differences. Further analyses of a longitudinal sample of 400 individuals receiving services at 11 residential treatment programs will be conducted. The specific aims of this study include: 1a) to determine whether trauma exposure is associated with primary treatment outcomes at the 6- and 12-month follow-ups; 1b) to examine whether the association between trauma exposure and treatment outcomes is mediated by the presence of PTSD; to determine if the association between PTSD and treatment outcomes is mediated by changes in trauma related symptoms and psychological distress; 2) examine whether the participation in specific treatment services mediate and/or moderate the relationship between trauma exposure/PTSD and treatment outcomes; and 3) to examine whether the patterns of association identified for each of these aims differ by gender. Regression models based on the generalized estimating equations approach will be employed to examine the longitudinal relationship between the variables of interest. Several methodological strengths of the proposed study provide a unique opportunity to address gaps in the literature. Specifically: 1) the use of structured clinical interviews to diagnose SUDs, SMI, and PTSD according to DSM-IV criteria; 2) repeated assessment of the variables of interest; 3) a sample of individuals receiving concurrent substance abuse and mental health services; and 4) the inclusion of sufficient males and females to allow for simultaneous gender comparisons. In sum, the findings of the present study can aid in the development of treatment interventions that better address the needs of individuals with multiple comorbid disorders.
描述(由申请人提供):拟议的研究将考察创伤暴露和创伤后应激障碍(PTSD)对共病物质使用障碍(sud)和严重精神疾病(SMI)患者主要治疗结果的综合影响,并注意性别差异。将对在11个住院治疗项目中接受服务的400人的纵向样本进行进一步分析。本研究的具体目的包括:1a)确定创伤暴露是否与6个月和12个月随访时的主要治疗结果相关;1b)研究创伤暴露与治疗结果之间的关联是否由PTSD的存在介导;确定创伤后应激障碍与治疗结果之间的关联是否由创伤相关症状和心理困扰的改变介导;2)研究是否参与特定治疗服务调解和/或调节创伤暴露/PTSD与治疗结果之间的关系;3)检查每个目标的关联模式是否因性别而异。基于广义估计方程方法的回归模型将被用来检验感兴趣的变量之间的纵向关系。提出的研究的几个方法学优势提供了一个独特的机会来解决文献中的空白。具体而言:1)根据DSM-IV标准,使用结构化临床访谈诊断sud、SMI和PTSD;2)重复评估感兴趣的变量;3)同时接受药物滥用和精神卫生服务的个体样本;4)包括足够的男性和女性,以便同时进行性别比较。总之,本研究的发现有助于开发治疗干预措施,更好地满足患有多种共病的个体的需求。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

VIRGINIA GIL-RIVAS其他文献

VIRGINIA GIL-RIVAS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('VIRGINIA GIL-RIVAS', 18)}}的其他基金

Parent-Child Relation /Child Adjustment Post Hurricane
亲子关系/飓风后的儿童调整
  • 批准号:
    7146579
  • 财政年份:
    2006
  • 资助金额:
    $ 6.63万
  • 项目类别:
The Parent-Child Relationship and Children's Adjustment Post-Hurricane Katrina
卡特里娜飓风后亲子关系与儿童适应
  • 批准号:
    7214734
  • 财政年份:
    2006
  • 资助金额:
    $ 6.63万
  • 项目类别:
Treatment outcomes, comorbid disorders and PTSD
治疗结果、合并症和 PTSD
  • 批准号:
    7112416
  • 财政年份:
    2005
  • 资助金额:
    $ 6.63万
  • 项目类别:

相似海外基金

Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tazemetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer
EZH2 抑制剂、他泽美司他和 PD-1 阻断治疗晚期非小细胞肺癌的安全性和有效性的 Ib/II 期研究
  • 批准号:
    10481965
  • 财政年份:
    2024
  • 资助金额:
    $ 6.63万
  • 项目类别:
睡眠時無呼吸症と睡眠時ブラキシズムのcomorbidityを成立させる病態生理機構の解明
阐明睡眠呼吸暂停和睡眠磨牙症并存的病理生理机制
  • 批准号:
    24K02631
  • 财政年份:
    2024
  • 资助金额:
    $ 6.63万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Longitudinal Modeling of Pro-Inflammatory Cytokines, Hazardous Alcohol Use, and Cerebral Metabolites as Predictors of Neurocognitive Change in People with HIV
促炎细胞因子、有害酒精使用和脑代谢物的纵向建模作为 HIV 感染者神经认知变化的预测因子
  • 批准号:
    10838849
  • 财政年份:
    2024
  • 资助金额:
    $ 6.63万
  • 项目类别:
Childhood trauma, hippocampal function, and anhedonia among those at heightened risk for psychosis
精神病高危人群中的童年创伤、海马功能和快感缺失
  • 批准号:
    10825287
  • 财政年份:
    2024
  • 资助金额:
    $ 6.63万
  • 项目类别:
Bilirubin Catabolism induces Plasminogen-Activator Inhibitor 1 (PAI-1) worsening Metabolic Dysfunction
胆红素分解代谢诱导纤溶酶原激活剂抑制剂 1 (PAI-1) 恶化代谢功能障碍
  • 批准号:
    10750132
  • 财政年份:
    2024
  • 资助金额:
    $ 6.63万
  • 项目类别:
ARISTOTELES - Applying ARtificial Intelligence to Define clinical trajectorieS for personalized predicTiOn and early deTEctiOn of comorbidiTy and muLtimorbidiTy pattErnS
亚里士多德 - 应用人工智能定义临床轨迹,以实现个性化预测以及合并症和多发病模式的早期检测
  • 批准号:
    10103153
  • 财政年份:
    2023
  • 资助金额:
    $ 6.63万
  • 项目类别:
    EU-Funded
Multimorbidity in Children and Youth Across the Life-course (MY LIFE): A Long-term Follow-up
儿童和青少年一生中的多重疾病(我的一生):长期随访
  • 批准号:
    483695
  • 财政年份:
    2023
  • 资助金额:
    $ 6.63万
  • 项目类别:
    Operating Grants
Neural activity-based candidate gene identification to link eating disorders and drug addiction
基于神经活动的候选基因识别将饮食失调和药物成瘾联系起来
  • 批准号:
    10528062
  • 财政年份:
    2023
  • 资助金额:
    $ 6.63万
  • 项目类别:
Project 3: 3-D Molecular Atlas of cerebral amyloid angiopathy in the aging brain with and without co-pathology
项目 3:有或没有共同病理的衰老大脑中脑淀粉样血管病的 3-D 分子图谱
  • 批准号:
    10555899
  • 财政年份:
    2023
  • 资助金额:
    $ 6.63万
  • 项目类别:
Centrally-linked longitudinal peripheral biomarkers of AD in multi-ethnic populations
多种族人群中 AD 的中心连锁纵向外周生物标志物
  • 批准号:
    10555723
  • 财政年份:
    2023
  • 资助金额:
    $ 6.63万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了